---
title: "IMM: Discontinuation of TACTI-004 caused impairment, but strong cash and positive clinical data support future prospects"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297439554.md"
description: "FY2026 saw a major setback with the discontinuation of the TACTI-004 trial and a resulting impairment, but positive clinical data in other programs and a strategic licensing deal with Dr Reddy's supported revenue growth. The company ended the year with A$68.9M in cash and expects a reduced loss in FY2027.Original document: Immutep Ltd [IMM] Annual Report — Aug. 30 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-30T23:34:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297439554.md)
  - [en](https://longbridge.com/en/news/297439554.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297439554.md)
generator: "portal-rs"
---

# IMM: Discontinuation of TACTI-004 caused impairment, but strong cash and positive clinical data support future prospects

FY2026 saw a major setback with the discontinuation of the TACTI-004 trial and a resulting impairment, but positive clinical data in other programs and a strategic licensing deal with Dr Reddy's supported revenue growth. The company ended the year with A$68.9M in cash and expects a reduced loss in FY2027.

Original document: Immutep Ltd \[IMM\] Annual Report — Aug. 30 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [IMMP.US](https://longbridge.com/en/quote/IMMP.US.md)
- [IMM.AU](https://longbridge.com/en/quote/IMM.AU.md)
- [RDY.US](https://longbridge.com/en/quote/RDY.US.md)

## Related News & Research

- [Dr. Reddy's publishes TNFD-Aligned Nature Disclosure 2026 report](https://longbridge.com/en/news/297995972.md)
- [Coya Therapeutics posts September 2026 investor presentation on neurodegeneration pipeline](https://longbridge.com/en/news/297669200.md)
- [Iomart publishes 2026 annual report](https://longbridge.com/en/news/297739507.md)
- [Maris-Tech to showcase UAV video, AI modules at AUSA 2026](https://longbridge.com/en/news/298127031.md)
- [Pininfarina announces availability of H1 2026 interim financial report](https://longbridge.com/en/news/298044460.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**